Summary
Laser capture microdissection (LCM) is a powerful tool that enables the isolation of specific cell types from tissue sections, overcoming the problem of tissue heterogeneity and contamination. We combined the LCM with isotope-coded affinity tag (ICAT) technology and two-dimensional liquid chromatography to investigate the qualitative and quantitative proteomes of hepatocellular carcinoma (HCC). The effects of three different histochemical stains on tissue sections have been compared, and toluidine blue stain was proved as the most suitable stain for LCM followed by proteomic analysis. The solubilized proteins from microdissected HCC and non-HCC hepatocytes were qualitatively and quantitatively analyzed with two-dimensional liquid chromatography tandem mass spectrometry (2D-LC-MS/MS) alone or coupled with cleavable isotope-coded affinity tag (cICAT) labeling technology. A total of 644 proteins were qualitatively identified and 261 proteins were unambiguously quantified. These results showed that the clinical proteomic method using LCM coupled with ICAT and 2D-LC-MS/MS can carry out not only large-scale but also accurate qualitative and quantitative analysis.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Feitelson M.A., Sun B., Satiroglu Tufan N.L., Liu J., Pan J. and Lian Z. (2002) Genetic mechanisms of hepatocarcinogenesis. Oncogene 21, 2593–2604.
Fujiyama S., Tanaka M., Maeda S., Ashihara H., Hirata R. and Tomita K. (2002) Tumor markers in early diagnosis, follow-up and management of patients with hepatocellular carcinoma. Oncology 62(Suppl 1), 57–63.
Qin L.X. and Tang Z.Y. (2002) The prognostic molecular markers in hepatocellular carcinoma. World J Gastroenterol 8, 385–392.
Park K.S., Cho S.Y., Kim H. and Paik Y.K. (2002) Proteomic alterations of the variants of human aldehyde dehydrogenase isozymes correlate with hepatocellular carcinoma. Int J Cancer 97, 261–265.
Park K.S., Kim H., Kim N.G., Cho S.Y., Choi K.H., Seong J.K. and Paik Y.K. (2002) Proteomic analysis and molecular characterization of tissue ferritin light chain in hepatocellular carcinoma. Hepatology 35, 1459–1466.
Cho S.Y., Park K.S., Shim J.E., Kwon M.S., Joo K.H., Lee W.S., Chang J., Kim H., Chung H.C., Kim H.O. and Paik Y.K. (2002) An integrated proteome database for two-dimensional electrophoresis data analysis and laboratory information management system. Proteomics 2, 1104–1113.
Lim S.O., Park S.J., Kim W., Park S.G., Kim H.J., Kim Y.I., Sohn T.S., Noh J.H. and Jung G. (2002) Proteome analysis of hepatocellular carcinoma. Biochem Biophys Res Commun 291, 1031–1037.
Kim J., Kim S.H., Lee S.U., Ha G.H., Kang D.G., Ha N.Y., Ahn J.S., Cho H.Y., Kang S.J., Lee Y.J., Hong S.C., Ha W.S., Bae J.M., Lee C.W. and Kim J.W. (2002) Proteome analysis of human liver tumor tissue by two-dimensional gel electrophoresis and matrix assisted laser desorption/ionization-mass spectrometry for identification of disease-related proteins. Electrophoresis 23, 4142–4156.
Franzen B., Hirano T., Okuzawa K., Uryu K., Alaiya A.A., Linder S. and Auer G. (1995) Sample preparation of human tumors prior to two-dimensional electrophoresis of proteins. Electrophoresis 16, 1087–1089.
Emmert-Buck M.R., Bonner R.F., Smith P.D., Chuaqui R.F., Zhuang Z., Goldstein S.R., Weiss R.A. and Liotta L.A. (1996) Laser capture microdissection. Science 274, 998–1001.
Bonner R.F., Emmert-Buck M., Cole K., Pohida T., Chuaqui R., Goldstein S. and Liotta L.A. (1997) Laser capture microdissection: molecular analysis of tissue. Science 278, 1481–1483.
Ornstein D.K., Gillespie J.W., Paweletz C.P., Duray P.H., Herring J., Vocke C.D., Topalian S.L., Bostwick D.G., Linehan W .M., Petricoin E.F., III and Emmert-Buck M.R. (2000) Proteomic analysis of laser capture microdissected human prostate cancer and in vitro prostate cell lines. Electrophoresis 21, 2235–2242.
Jones M.B., Krutzsch H., Shu H., Zhao Y., Liotta L.A., Kohn E.C. and Petricoin E.F., III (2002) Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancer. Proteomics 2, 76–84.
Simone N.L., Remaley A.T., Charboneau L., Petricoin E.F., III, Glickman J.W., Emmert-Buck M.R., Fleisher T.A. and Liotta L.A. (2000) Sensitive immunoassay of tissue cell proteins procured by laser capture microdissection. Am J Pathol 156, 445–452.
Ornstein D.K., Englert C., Gillespie J.W., Paweletz C.P., Linehan W.M., Emmert-Buck M.R. and Petricoin E.F., III (2000) Characterization of intracellular prostate-specific antigen from laser capture microdissected benign and malignant prostatic epithelium. Clin Cancer Res 6, 353–356.
Sauter E.R., Zhu W., Fan X.J., Wassell R.P., Chervoneva I. and Du Bois G.C. (2002) Proteomic analysis of nipple aspirate fluid to detect biologic markers of breast cancer. Br J Cancer 86, 1440–1443.
Verma M., Wright G.L., Jr., Hanash S.M., Gopal-Srivastava R. and Srivastava S. (2001) Proteomic approaches within the NCI early detection research network for the discovery and identification of cancer biomarkers. Ann N Y Acad Sci 945, 103–115.
Jain K.K. (2002) Recent advances in oncoproteomics. Curr Opin Mol Ther 4, 203–209.
Jr G.W., Cazares L.H., Leung S.M., Nasim S., Adam B.L., Yip T.T., Schellhammer P.F., Gong L. and Vlahou A. (1999) ProteinChip® surface enhanced laser desorption/ionization (SELDI) mass spectrometry: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures. Prostate Cancer Prostatic Dis 2, 264–276.
Batorfi J., Ye B., Mok S.C., Cseh I., Berkowitz R.S. and Fulop V. (2003) Protein profiling of complete mole and normal placenta using ProteinChip analysis on laser capture microdissected cells. Gynecol Oncol 88, 424–428.
Wulfkuhle J.D., Paweletz C.P., Steeg P.S., Petricoin E.F., III and Liotta L. (2003) Proteomic approaches to the diagnosis, treatment, and monitoring of cancer. Adv Exp Med Biol 532, 59–68.
Seow T.K., Liang R.C., Leow C.K. and Chung M.C. (2001) Hepatocellular carcinoma: from bedside to proteomics. Proteomics 1, 1249–1263.
Yu L.R., Shao X.X., Jiang W.L., Xu D., Chang Y.C., Xu Y.H. and Xia Q.C. (2001) Proteome alterations in human hepatoma cells transfected with antisense epidermal growth factor receptor sequence. Electrophoresis 22, 3001–3008.
Yu L.R., Zeng R., Shao X.X., Wang N., Xu Y.H. and Xia Q.C. (2000) Identification of differentially expressed proteins between human hepatoma and normal liver cell lines by two-dimensional electrophoresis and liquid chromatography-ion trap mass spectrometry. Electrophoresis 21, 3058–3068.
Ding S.J., Li Y., Tan Y.X., Jiang M.R., Tian B., Liu Y.K., Shao X.X., Ye S.L., Wu J.R., Zeng R., Wang H.Y., Tang Z.Y. and Xia Q.C. (2004) From proteomic analysis to clinical significance: overexpression of cytokeratin 19 correlates with hepatocellular carcinoma metastasis. Mol Cell Proteomics 3(1), 73–81.
Gygi S.P., Rist B., Gerber S.A., Turecek F., Gelb M.H. and Aebersold R. (1999) Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol 17, 994–999.
Li J., Steen H. and Gygi S.P. (2003) Protein profiling with cleavable isotope coded affinity tag (cICAT) reagents: the yeast salinity stress response. Mol Cell Proteomics 2 (11), 1198–204.
Oda Y., Owa T., Sato T., Boucher B., Daniels S., Yamanaka H., Shinohara Y., Yokoi A., Kuromitsu J. and Nagasu T. (2003) Quantitative chemical proteomics for identifying candidate drug targets. Anal Chem 75, 2159–2165.
Hansen K.C., Schmitt-Ulms G., Chalkley R.J., Hirsch J., Baldwin M.A. and Burlingame A.L. (2003) Mass spectrometric analysis of protein mixtures at low levels using cleavable 13C-isotope-coded affinity tag and multidimensional chromatography. Mol Cell Proteomics 2, 299–314.
Washburn M.P., Wolters D. and Yates J.R., III (2001) Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol 19, 242–247.
Gygi S.P., Corthals G.L., Zhang Y., Rochon Y. and Aebersold R. (2000) Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology. Proc Natl Acad Sci USA 97, 9390–9395.
Kyte J. and Doolittle R.F. (1982) A simple method for displaying the hydropathic character of a protein. J Mol Biol 157, 105–132.
Craven R.A., Totty N., Harnden P., Selby P.J. and Banks R.E. (2002) Laser capture microdissection and two-dimensional polyacrylamide gel electrophoresis: evaluation of tissue preparation and sample limitations. Am J Pathol 160, 815–822.
Li C., Hong Y., Tan Y.X., Zhou H., Ai J.H., Li S.J., Zhang L., Xia Q.C., Wu J.R., Wang Y. and Zeng R. (2004) Accurate qualitative and quantitative proteomic analysis of clinical hepatocellular carcinoma using laser capture microdissection coupled with isotope-coded affinity tag and two-dimensional liquid chromatography mass spectrometry. Mol Cell Proteomics 3(4), 399–409.
Acknowledgments
This work was supported by National High-Technology Project (2001AA233031, 2002BA711A11) and Basic Research Foundation (2001CB210501).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Li, C. et al. (2008). Analysis of Microdissected Cells by Two-Dimensional LC-MS Approaches. In: Vlahou, A. (eds) Clinical Proteomics. Methods in Molecular Biology™, vol 428. Humana Press. https://doi.org/10.1007/978-1-59745-117-8_11
Download citation
DOI: https://doi.org/10.1007/978-1-59745-117-8_11
Publisher Name: Humana Press
Print ISBN: 978-1-58829-837-9
Online ISBN: 978-1-59745-117-8
eBook Packages: Springer Protocols